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Youth, which is forgiven everything, forgives itself  nothing: age, which 
forgives itself  everything, is forgiven nothing. – George Bernard Shaw
The proportion of  older people in the general population 
is steadily increasing worldwide, with the most rapid growth 
in low- and middle-income countries [1]. This demographic 
change is to be celebrated, because it is the consequence of  
socio-economic development and a better life expectancy. 
However, population aging also has important implications 
on society – in diverse areas including health systems, labour 
markets, public policy, social programmes, and family 
dynamics [2]. A successful response to the aging population 
will require capitalising on opportunities this transition 
offers, as well as effectively addressing its challenges.
Chronic kidney disease (CKD) is an important public 
health problem, characterised by poor health outcomes and 
very high healthcare costs. CKD is a major risk multiplier 
in patients with diabetes, hypertension, heart disease and 
stroke – all of  which are key causes of  death and disability 
in older people [3]. Since the prevalence of  CKD is higher 
in older people, the health impact of  population aging will 
depend in part on how the kidney community responds. 
March 13, 2014 marked the celebration of  the 9th World 
Kidney Day (WKD), an annual event jointly sponsored 
by the International Society of  Nephrology and the 
International Federation of  Kidney Foundations. Since its 
inception in 2006, WKD has become the most successful 
effort to raise awareness among policymakers and the 
general public about the importance of  kidney disease. The 
topic for WKD 2014 was “CKD in older people”. This 
article reviews the key links between kidney function, age, 
health and illness – and discusses the implications of  the 
aging population for the care of  people with CKD.
epiDeMiology of Aging
The key drivers of  population aging are socio-economic 
development and increasing prosperity – which result in 
lower perinatal, infant and childhood mortality; lower risk of  
death in early adulthood due to accidents and unsafe living 
conditions; and improving survival of  middle-aged and 
older people due to chronic disease. The resulting increases 
in life expectancy (together with the lower birth rates that 
typically accompany socio-economic development) mean 
that older people account for a larger proportion of  the 
general population [1]. The extent of  the resulting changes 
in population characteristics can be startling, especially for 
developing countries (Figure 1).
In contrast to the situation even two generations ago, 
people can expect to live for many years after the usual 
retirement age. For example, UK men and women aged 
65 years in 2030 can expect to live until age 88 and 91 
years respectively [4]. Predicted life expectancy for today’s 
children is controversial, but experts estimate that 50% of  
children born in the UK in 2007 will live to at least 103 
years [4]. Although it is clear that people are living longer, 
it is uncertain how much of  the increased life expectancy 
will translate into years of  good health. These demographic 
changes have dramatic potential implications for conditions 
such as CKD, for which the prevalence increases with age.
cKD is coMMon in olDer people AnD its 
preVAlence increAses in pArAllel With 
Age
It has been known for decades that estimated glomerular 
filtration rate (eGFR) declines in parallel with age [5]. The 
prevalence of  CKD among females in the Chinese general 
population increases from 7.4% among those aged 18-39 
years to 18.0% and 24.2% among those aged 60-69 and 70 
years respectively [6]. Relative increases in the prevalence 
of  CKD with age are equally striking for populations in the 
US, Canada and Europe [7-9], although there are between-
country differences in the absolute prevalence. 
At older ages, an increased proportion of  prevalent CKD 
cases has low eGFR alone (as compared to albuminuria 
alone, or both low eGFR and albuminuria) [10]. Although 
this might suggest that many older people with CKD can 
expect lower rates of  kidney function loss, available data 
is inconclusive – and current knowledge does not allow 
clinicians to reliably distinguish between those whose CKD 
will and will not progress. 
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As for other age groups, the incidence of  dialysis-dependent 
kidney failure has steadily increased among older people 
over the last few decades: in the US, a 57% age-adjusted 
increase in the number of  incident octogenarians and 
nonagenarians was noted between 1996 and 2003 alone 
[11]. Despite this increase, patients aged >80 years are still 
less likely to initiate dialysis than those aged 75-79 years – 
although a recent sizeable study suggested that the risk of  
developing very low eGFR (<15 ml/min/1.73m2) is similar 
for older and younger adults [12]. It is uncertain whether this 
discrepancy is due to between-age differences in the true 
rate of  progressive kidney function loss, the risk of  death 
due to competing causes, patient views about dialysis, or 
physician practices [12, 13]. Regardless of  the explanation, 
the aging population will likely lead to continued increases 
in the number of  older people with severe CKD.
cKD is hArMful But treAtABle if 
pAtients At risK Are iDentifieD 
Like younger people, older people with advanced CKD are at 
increased risk of  death, kidney failure, myocardial infarction 
and stroke compared to otherwise similar people with 
normal or mildly reduced eGFR [14, 15]. Although death 
is by far the most common of  these adverse outcomes, this 
does not mean that older patients with clinically relevant 
CKD cannot benefit from timely specialist referral. 
With appropriate management, patients with advanced 
CKD (regardless of  age) may benefit from slower loss 
of  kidney function (potentially preventing kidney failure), 
better control of  metabolic consequences such as 
acidosis, anaemia and hyperphosphatemia, lower risk of  
cardiovascular events, and (for those who are interested 
in renal replacement) a more informed choice of  renal 
replacement modality, including timely creation of  vascular 
access [16]. The aging population will likely lead to continued 
increases in the number of  older people who might require 
such referral, which should be considered in assessments of  
future nephrology workforce capacity.
DiAlysis cAn Benefit olDer people 
With KiDney fAilure
In developed countries, the default management strategy 
for older people with kidney failure appears to have shifted 
from conservative management to initiation of  dialysis [17]. 
On average, life expectancy after initiation of  dialysis is 
relatively short for older patients: median survival among 
US dialysis patients aged 80-84 years is 16 months – and is 
only 12 months for those aged 85-89 years [11]. At the same 
time, these median statistics reflect a bimodal distribution 
of  survival time in older dialysis patients: although a large 
proportion die within six months of  commencing dialysis, 
a substantial minority may live for years. This heterogeneity 
in mortality appears to be driven by differences in baseline 
comorbidity. For example, analyses of  a small UK cohort of  
people with advanced kidney failure suggested that initiation 
of  dialysis was not associated with increased survival for 
those aged >75 and with two or more comorbidities [18, 19]. 
Similarly, the presence of  two to three comorbid conditions 
in US dialysis patients aged >65 years was associated with 
substantially increased mortality compared to those in better 
health [11]. When functional status is lower at baseline, 
initiation of  dialysis often signals the onset of  further 
declines: among 3,702 nursing home residents initiating 
dialysis, 58% had died and 87% had experienced additional 
loss of  function at one year. [20]. Although available data 
is limited, the quality of  life appears reasonable among 
selected older dialysis patients – and can remain stable 
despite moderate or high levels of  comorbidity [21, 22].
This data suggests that dialysis is an appropriate treatment 
option for well-informed older patients with kidney failure 
– especially for those with good baseline quality of  life. On 
the other hand, the poor outcomes experienced in those 
with more comorbidity or lower functional status at baseline 
clearly demonstrates that dialysis does not improve clinical 
outcomes for all older people with kidney failure – and that 
good clinical judgment and careful communication will be 
increasingly required as the general population continues to 
age.
KiDney trAnsplAntAtion cAn Also 
Benefit olDer people With KiDney 
fAilure
It is generally accepted that an older age alone does not 
preclude kidney transplantation in otherwise suitable 
candidates. However, older patients with kidney failure are 
more likely to have absolute and relative contraindications 
to transplantation, and are less likely to be placed on the 
kidney transplantation waiting list. Unsurprisingly, patient 
and graft five-year survival probabilities are lower among 
US kidney transplant recipients older than 65 years as 
compared to those aged between 35 and 49 years (patient: 
67.2% vs 89.6%; graft: 60.9% vs 75.4%, respectively) [23]. 
In addition, older people who are possible transplant 
recipients face several potential disadvantages compared to 
their younger counterparts (Box 1).
Nonetheless, transplantation appears to reduce mortality 
among patients of  all ages. For example, among those 
aged 74 years, receiving a deceased donor transplant was 
associated with a hazard ratio of  mortality of  0.67 (95% 
confidence interval 0.53, 0.86) as compared to remaining 
on dialysis [23]. Use of  expanded criteria deceased donors 
[24, 25] as well as more liberal use of  older living donors 
[26] also appear to reduce mortality among older people 
with kidney failure, as compared to similar patients who 
remain on the transplant waiting list (Box 2). These latter 
two strategies are especially appealing for use in developing 
countries, where growth in the prevalence of  older people 
has been most pronounced. However, because transplant 
surgery itself  temporarily increases the risk of  death, the 
mortality benefits associated with kidney transplantation 
(regardless of  donor type) are restricted to those with 
reasonable baseline life expectancy and without dramatically 
increased perioperative risk [27].
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reseArch neeDs
Although much is known about chronic kidney disease in 
older populations, a great deal remains to be learned. Many 
trials of  therapies for CKD have excluded older patients 
[28] – and most do not provide guidance on how to manage 
comorbidities that often accompany CKD but may lead 
to competing therapeutic priorities. More information 
is needed on how to accurately identify people who will 
progress to kidney failure – and among these, the subset 
that can expect reasonable life expectancy and quality of  
life if  they opt for dialysis treatment. Future studies should 
test new ways to communicate information about the 
risks and benefits of  dialysis (as compared to conservative 
management), to facilitate informed patient decisions. 
Above all, we need more studies that demonstrate how to 
optimise quality of  life and manage symptoms in elderly 
people with CKD – including those who have chosen 
conservative management. 
the WAy forWArD
The aging of  the general population means that older people 
now account for a much greater proportion of  patients 
with or at risk for kidney disease and kidney failure. The 
tremendous clinical heterogeneity within this population 
indicates the need for more discerning management. 
Chronological age alone will not be sufficient as the basis for 
clinical decisions, and a more nuanced approach is required 
– based on the comorbidities, functional status, quality of  
life and preferences of  each individual patient. Clinicians 
can be reassured that dialysis and kidney transplantation can 
increase life expectancy – and will allow reasonable quality 
of  life in selected older people with kidney failure. Perhaps 
more importantly, clinicians, patients and their families 
can be comforted by the knowledge that timely specialist 
evaluation can help to improve outcomes and reduce 
symptoms in older people with advanced kidney disease 
– whether they have selected conservative management or 
dialysis as their treatment plan.
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Box 1: unmet needs for kidney transplantation in 
older cKD patients
 ● Organ shortage.
 ● Paucity of  live donors.
 ● Organ allocation policies that appropriately weight 
likelihood of  benefit from transplantation as well as 
chronological age.
 ● Ensuring appropriate referral of  potentially suitable 
older recipients for transplantation assessment.
 ● Ethical concerns about offering a kidney to an older 
patient versus a younger one.
 ● Optimal immunosuppressive regimen.
Adapted from reference [29].
Box 2:  Meeting the growing demand for kidney 
transplantation in older cKD patients
 ● Preferential transplantation of  organs from older 
donors to older recipients.
 ● Enlarge the donor pool by accepting expanded 
criteria donors: ≥60 years old or ≥ 50 with any of  the 
following two conditions: history of  hypertension, 
serum creatinine ≥1.5 mg/dl or death due to 
cerebrovascular accident.
 ● “Old for old”: preferentially using kidneys from 
older living donors for older recipients.
 ● Transplanting two marginal kidneys instead of  one.
Adapted from reference [29].
9Chronic Kidney Disease And The Aging Population 
African Journal of  Nephrology (2014) 17 (1)
Figure 1: Changing age distribution in general population of China, 1990-2050
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